David Standa

Office Phone:

(773) 395-1601

Direct Phone:

(773) 395-1562


  Pro - Try 1 Week Free
 

    and access,

  •     81K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     201K Transactions
  •     203K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

David Standa is a partner in the Cannabis Law practice group at Greenspoon Marder. He currently focuses on the rapidly evolving cannabis industry and how recently passed legislation, like state-level legalization statutes and many pending federal regulations, impact companies with marijuana, hemp and CBD products. Mr. Standa advises cannabis clients throughout the Midwest on topics ranging from state-level licensing issues, compliance with seed-to-sale tracking requirements, tax issues, and litigation. Mr. Standa is a frequent speaker on cannabis issues, including the FDA’s regulation of CBD products, the potential liability arising out of CBD and edible marijuana products, packaging and labeling, and navigating Illinois’ Cannabis Regulation and Tax Act. Additionally, Mr. Standa has extensive experience in business and consumer finance litigation as well as corporate transactions, securities and regulatory matters, food and beverage compliance and litigation, and healthcare litigation. He has defended several alcoholic beverage industry clients in class actions alleging deceptive labeling and marketing practices, and has assisted industry clients with compliance in the development of product labels. Mr. Standa is also engaged in health insurance reimbursement disputes. He has represented insurers and hospital systems in litigation and arbitration involving insurance and healthcare disputes and arbitrations, including complex issues surrounding the business of insurance, insurance regulatory matters, Medicare/Medicaid disputes and False Claims Act litigation. At his previous firm, Mr. Standa advised a national health insurance provider on a series of joint ventures with regional hospital systems involving the creation of new insurance networks, and provided regulatory guidance about potential statutory exposure to an insurance holding company.

Education